Clinical Trial Update: A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In Adolescents [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the safety and immune response of the Novartis Meningococcal ACWY Conjugate Vaccine in adolescents has completed with results posted in…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Disease
• Meningococcal Meningitis

Drugs mentioned

• Menveo (meningococcal group A, C, W-135 and Y conjugate vaccine)

Snippet

Sponsor: Novartis Vaccines | Conditions: Meningococcal Meningitis, Human Papillomavirus Infection | Phase 3 | Status: COMPLETED | Results posted: 2010-10-04